ZERO Prostate Cancer Urges Congress to Pass Critical FY 2026 Funding to Advance Research and Expand Access to Care January 21, 2026 FOR IMMEDIATE RELEASEMedia Contact:Milayo Olufemi, Health Communications ManagerZERO Prostate Cancermilayo.olufemi@zerocancer.org | media@zerocancer.org WASHINGTON, D.C. — ZERO Prostate Cancer, the nation's #1 provider of prostate cancer resources, programs, and services to those at risk, diagnosed, and their families, is calling on Congress to pass the final FY 2026 appropriations bills and associated health provisions without delay. For the three million men living with prostate cancer in America, this legislation isn't just policy—it's progress that saves lives. By passing this funding package, Congress has the opportunity to ensure prostate cancer research continues moving forward, and early detection—which offers a 99% survival rate—becomes accessible to more men and families nationwide.What's in the FY 2026 bill for the prostate cancer community:Sustained funding for the Prostate Cancer Research Program—the cornerstone of our fight for better treatments and outcomes.A $1 million increase for CDC prostate cancer activities to expand outreach where it's needed most.Increased funding for the National Cancer Institute to advance breakthroughs in prostate cancer research.The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act—bringing FDA-approved multi-cancer screenings to Medicare patients at a time when early detection can mean the difference between life and death.Expanded Medicare telehealth services so every Medicare patient can access care regardless of location.Continued funding for Community Health Centers that provide critical access points for patients across the country.ZERO advocates are contacting members of Congress today with a clear message: support this critical funding. If you feel strongly about advancing prostate cancer research and improving access to care, we encourage you to contact your representatives and make your voice heard.To learn how to contact your members of Congress or for more information about ZERO's advocacy work, visit ZEROCancer.org. About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org More for Press & Media Press Releases Press Releases Explore our newsroom for press releases and official statements about ZERO's latest updates, achievements, and partnerships. Press & Media Inquiries Press & Media Inquiries See how to contact ZERO's media contacts for press inquiries, logo and brand guidelines, and our recent press releases. Media Kits Media Kits Find essential tools to enhance your storytelling and coverage about ZERO. Advocacy Press Release More for you
ZERO Prostate Cancer Urges Congress to Pass Critical FY 2026 Funding to Advance Research and Expand Access to Care January 21, 2026
FOR IMMEDIATE RELEASEMedia Contact:Milayo Olufemi, Health Communications ManagerZERO Prostate Cancermilayo.olufemi@zerocancer.org | media@zerocancer.org
WASHINGTON, D.C. — ZERO Prostate Cancer, the nation's #1 provider of prostate cancer resources, programs, and services to those at risk, diagnosed, and their families, is calling on Congress to pass the final FY 2026 appropriations bills and associated health provisions without delay. For the three million men living with prostate cancer in America, this legislation isn't just policy—it's progress that saves lives. By passing this funding package, Congress has the opportunity to ensure prostate cancer research continues moving forward, and early detection—which offers a 99% survival rate—becomes accessible to more men and families nationwide.What's in the FY 2026 bill for the prostate cancer community:Sustained funding for the Prostate Cancer Research Program—the cornerstone of our fight for better treatments and outcomes.A $1 million increase for CDC prostate cancer activities to expand outreach where it's needed most.Increased funding for the National Cancer Institute to advance breakthroughs in prostate cancer research.The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act—bringing FDA-approved multi-cancer screenings to Medicare patients at a time when early detection can mean the difference between life and death.Expanded Medicare telehealth services so every Medicare patient can access care regardless of location.Continued funding for Community Health Centers that provide critical access points for patients across the country.ZERO advocates are contacting members of Congress today with a clear message: support this critical funding. If you feel strongly about advancing prostate cancer research and improving access to care, we encourage you to contact your representatives and make your voice heard.To learn how to contact your members of Congress or for more information about ZERO's advocacy work, visit ZEROCancer.org.
About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org
More for Press & Media Press Releases Press Releases Explore our newsroom for press releases and official statements about ZERO's latest updates, achievements, and partnerships. Press & Media Inquiries Press & Media Inquiries See how to contact ZERO's media contacts for press inquiries, logo and brand guidelines, and our recent press releases. Media Kits Media Kits Find essential tools to enhance your storytelling and coverage about ZERO.
Donate Now
